Texas employers can no longer use fears of workers getting dizzy or blacking out on the job as an excuse to ban the hiring of applicants who use insulin to control their diabetes.
Read More »Diabetes In Control
Issue 125 Item 10 Pupil Test Detects Future Autonomic Neuropathy in Diabetic Pat
Pupil tests may be one way of diagnosing [autonomic dysfunction] as early a possible.
Read More »Kidney Disease Is Related to How Well Insulin Works
Insulin resistance, a condition commonly associated with the development of type 2 diabetes, is likely a major cause of kidney disease, or nephropathy, in people with type 1 diabetes.
Read More »Issue 123 Item 1 Diabetes Nurses Use PDAs in Patient Care
Patients with diabetes get faster attention with fewer potential errors thanks to nurses with personal data assistants (PDAs).
Read More »Issue 126 Item 14 Glipizide GITS Has Advantages Over Other Second-Generation Sul
Once daily dosing improves outcomes with better compliance.
Read More »Serious Health Risks From Impaired Glucose Tolerance
IGT and IFG are major risk factors for future diabetes and cardiovascular disease (CVD) and the need for urgent intervention.
Read More »Issue 124 Item 5 HRT Tied to Better Glycemic Control in Diabetic Women
Diabetic women who receive hormone replacement therapy (HRT) have lower glucose levels and better cholesterol profiles than their counterparts who do not receive HRT
Read More »Issue 126 Item 3 Simvastatin Protects against Endothelial Dysfunction in Type 2
Simvastatin minimizes oxidative stress and endothelial dysfunction brought on by the cumulative effects of postprandial hypertriglyceridemia and hyperglycemia seen in type 2 diabetics.
Read More »Issue 121 Item 12 ESC: Losartan Reduces Incidence of End-Stage Renal Disease
Researchers have found that losartan, an angiotensin II receptor blocker, can protect diabetic patients with nephropathy from end-stage renal disease. 44,000 cases could have been prevented over 3.5 years.
Read More »Issue 123 Item 11 Stem Cells Key to Diabetes Cure
There are not nearly enough donors to go around. Seven hundred thousand people in the United States have type 1 diabetes (islet cell transplantation can’t treat most cases of type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.